In a significant development, patent board judges have decided to annul all the claims in a patent related to a method for treating sleep apnea. This decision arose from a challenge by a San Diego-based sleep apnea company. The company contends that these claims constitute “97 percent” of a pending patent case concerning sleep apnea devices currently being deliberated in a federal court in Delaware.
This move by the Patent Trial and Appeal Board (PTAB) could have notable implications for ongoing and future litigations related to sleep apnea technologies. For further details, the original article is available on Law360.